Neurorehabilitation Robotics Market Forecasts to 2034– Global Analysis By Component (Hardware and Software), Type, Application, End User and By Geography
According to Stratistics MRC, the Global Neurorehabilitation Robotics Market is accounted for $1.20 billion in 2026 and is expected to reach $4.95 billion by 2034 growing at a CAGR of 19.3% during the forecast period. Neurorehabilitation robotics refers to the application of advanced robotic systems and intelligent technologies to support the recovery of individuals with neurological impairments. These systems are designed to assist, enhance, or restore motor and cognitive functions affected by conditions such as stroke, spinal cord injury, and Parkinson’s disease. They include robotic exoskeletons, end effector devices, and therapy robots that enable repetitive, precise, and adaptive training. By integrating sensors, artificial intelligence, and real-time feedback, neurorehabilitation robotics improves patient outcomes, enhances therapy efficiency, and supports personalized rehabilitation across clinical and home-based settings.
Market Dynamics:
Driver:
Rising incidence of neurological disorders
The increasing prevalence of neurological disorders such as stroke, spinal cord injury, and Parkinson’s disease is a major driver for the neurorehabilitation robotics market. These conditions often result in long-term motor impairments requiring intensive rehabilitation. As patient volumes rise globally, healthcare systems are adopting robotic solutions to deliver consistent, high-quality therapy. Neurorehabilitation robots enhance recovery outcomes through repetitive, precise movements, making them essential tools in modern rehabilitation practices and significantly boosting market demand.
Restraint:
High cost of robotic systems
The high cost of neurorehabilitation robotic systems remains a significant barrier to widespread adoption. These advanced devices involve substantial expenses related to procurement, installation, maintenance, and training. Smaller healthcare facilities and clinics, particularly in developing regions, often struggle to justify such investments. Additionally, limited reimbursement policies further restrict accessibility for patients. Despite their clinical benefits, the financial burden associated with these systems slows market penetration and creates disparities in access to advanced rehabilitation technologies across different regions.
Opportunity:
Technological advancements in robotics & AI
Rapid advancements in robotics, artificial intelligence, and sensor technologies present strong growth opportunities for the market. Innovations such as real-time feedback systems, adaptive learning algorithms, and improved human-machine interfaces are enhancing the effectiveness of rehabilitation therapies. These technologies enable personalized treatment plans and improve patient engagement and outcomes. Furthermore, the development of compact, user-friendly, and cost-effective robotic systems is expanding their application beyond hospitals into home-based care, significantly broadening the market’s potential globally.
Threat:
Regulatory and approval challenges
Regulatory and approval challenges pose a significant threat to the neurorehabilitation robotics market. These devices must comply with stringent medical device regulations, safety standards, and clinical validation requirements, which vary across regions. The approval process can be lengthy and costly, delaying product commercialization and innovation. Additionally, the lack of standardized guidelines for robotic rehabilitation systems complicates market entry. These regulatory hurdles increase operational risks for manufacturers and may limit the timely availability of advanced solutions in the market.
Covid-19 Impact:
The COVID-19 pandemic had a mixed impact on the market. While initial disruptions affected manufacturing, supply chains, and elective rehabilitation services, the crisis accelerated the adoption of automated and remote rehabilitation solutions. The need to minimize physical contact increased interest in robotic-assisted therapy and tele-rehabilitation. Healthcare providers began integrating advanced technologies to ensure continuity of care. As a result, the pandemic highlighted the value of robotics in rehabilitation, ultimately supporting long-term market growth despite short-term setbacks.
The lower limb robots segment is expected to be the largest during the forecast period
The lower limb robots segment is expected to account for the largest market share during the forecast period, due to high prevalence of mobility impairments caused by neurological conditions. These robots are widely used in gait training and mobility restoration, particularly for patients recovering from stroke or spinal cord injuries. Their ability to provide repetitive, controlled movement enhances rehabilitation outcomes. Increasing demand for effective mobility solutions, along with advancements in exoskeleton technologies, is driving the widespread adoption of lower limb robotic systems.
The stroke rehabilitation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the stroke rehabilitation segment is predicted to witness the highest growth rate, due to the rising global incidence of stroke and the need for intensive post-stroke therapy. Stroke patients often require long-term rehabilitation to regain motor functions, creating strong demand for robotic-assisted solutions. These systems enable precise, repetitive movements that improve recovery outcomes. Growing awareness about early rehabilitation and technological advancements are further accelerating the adoption of robotics in stroke treatment programs.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its large patient population and rapidly aging demographics. Increasing prevalence of neurological disorders, coupled with improving healthcare infrastructure, is driving demand for advanced rehabilitation solutions. Governments are investing in healthcare modernization and promoting the adoption of innovative technologies. Additionally, the presence of emerging economies and growing awareness about rehabilitation therapies contribute significantly to the region’s dominant position in the market.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong technological advancements and high healthcare spending. The region benefits from early adoption of innovative robotic systems and the presence of leading market players. Increasing focus on improving rehabilitation outcomes and reducing long-term healthcare costs is driving demand. Additionally, supportive regulatory frameworks, ongoing research activities, and growing awareness about advanced rehabilitation technologies are contributing to the region’s rapid market growth.
Key players in the market
Some of the key players in Neurorehabilitation Robotics Market include Ekso Bionics Holdings, Inc., Cyberdyne Inc., Bionik Laboratories Corp., Hocoma AG (DIH Medical Group), ReWalk Robotics Ltd., Lifeward, Inc., Tyromotion GmbH, Fourier Intelligence, Myomo, Inc., Kinova Inc., Rehab-Robotics Company Limited, AlterG, Inc., Wandercraft SAS, MediTouch Ltd. and Rex Bionics Ltd.
Key Developments:
In January 2026, Lifeward entered a strategic partnership with Oramed to transform into a diversified biomedical innovation company, integrating Oramed’s oral drug delivery technology while gaining access to up to $47 million in funding to support profitability and long-term growth.
In December 2025, Ekso Bionics entered an agreement with MediTouch to become the exclusive U.S. distributor of its BalanceTutor rehabilitation system, expanding its product portfolio and strengthening its position in neurorehabilitation by offering advanced balance training solutions to healthcare providers.
Components Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Market Dynamics:
Driver:
Rising incidence of neurological disorders
The increasing prevalence of neurological disorders such as stroke, spinal cord injury, and Parkinson’s disease is a major driver for the neurorehabilitation robotics market. These conditions often result in long-term motor impairments requiring intensive rehabilitation. As patient volumes rise globally, healthcare systems are adopting robotic solutions to deliver consistent, high-quality therapy. Neurorehabilitation robots enhance recovery outcomes through repetitive, precise movements, making them essential tools in modern rehabilitation practices and significantly boosting market demand.
Restraint:
High cost of robotic systems
The high cost of neurorehabilitation robotic systems remains a significant barrier to widespread adoption. These advanced devices involve substantial expenses related to procurement, installation, maintenance, and training. Smaller healthcare facilities and clinics, particularly in developing regions, often struggle to justify such investments. Additionally, limited reimbursement policies further restrict accessibility for patients. Despite their clinical benefits, the financial burden associated with these systems slows market penetration and creates disparities in access to advanced rehabilitation technologies across different regions.
Opportunity:
Technological advancements in robotics & AI
Rapid advancements in robotics, artificial intelligence, and sensor technologies present strong growth opportunities for the market. Innovations such as real-time feedback systems, adaptive learning algorithms, and improved human-machine interfaces are enhancing the effectiveness of rehabilitation therapies. These technologies enable personalized treatment plans and improve patient engagement and outcomes. Furthermore, the development of compact, user-friendly, and cost-effective robotic systems is expanding their application beyond hospitals into home-based care, significantly broadening the market’s potential globally.
Threat:
Regulatory and approval challenges
Regulatory and approval challenges pose a significant threat to the neurorehabilitation robotics market. These devices must comply with stringent medical device regulations, safety standards, and clinical validation requirements, which vary across regions. The approval process can be lengthy and costly, delaying product commercialization and innovation. Additionally, the lack of standardized guidelines for robotic rehabilitation systems complicates market entry. These regulatory hurdles increase operational risks for manufacturers and may limit the timely availability of advanced solutions in the market.
Covid-19 Impact:
The COVID-19 pandemic had a mixed impact on the market. While initial disruptions affected manufacturing, supply chains, and elective rehabilitation services, the crisis accelerated the adoption of automated and remote rehabilitation solutions. The need to minimize physical contact increased interest in robotic-assisted therapy and tele-rehabilitation. Healthcare providers began integrating advanced technologies to ensure continuity of care. As a result, the pandemic highlighted the value of robotics in rehabilitation, ultimately supporting long-term market growth despite short-term setbacks.
The lower limb robots segment is expected to be the largest during the forecast period
The lower limb robots segment is expected to account for the largest market share during the forecast period, due to high prevalence of mobility impairments caused by neurological conditions. These robots are widely used in gait training and mobility restoration, particularly for patients recovering from stroke or spinal cord injuries. Their ability to provide repetitive, controlled movement enhances rehabilitation outcomes. Increasing demand for effective mobility solutions, along with advancements in exoskeleton technologies, is driving the widespread adoption of lower limb robotic systems.
The stroke rehabilitation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the stroke rehabilitation segment is predicted to witness the highest growth rate, due to the rising global incidence of stroke and the need for intensive post-stroke therapy. Stroke patients often require long-term rehabilitation to regain motor functions, creating strong demand for robotic-assisted solutions. These systems enable precise, repetitive movements that improve recovery outcomes. Growing awareness about early rehabilitation and technological advancements are further accelerating the adoption of robotics in stroke treatment programs.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its large patient population and rapidly aging demographics. Increasing prevalence of neurological disorders, coupled with improving healthcare infrastructure, is driving demand for advanced rehabilitation solutions. Governments are investing in healthcare modernization and promoting the adoption of innovative technologies. Additionally, the presence of emerging economies and growing awareness about rehabilitation therapies contribute significantly to the region’s dominant position in the market.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong technological advancements and high healthcare spending. The region benefits from early adoption of innovative robotic systems and the presence of leading market players. Increasing focus on improving rehabilitation outcomes and reducing long-term healthcare costs is driving demand. Additionally, supportive regulatory frameworks, ongoing research activities, and growing awareness about advanced rehabilitation technologies are contributing to the region’s rapid market growth.
Key players in the market
Some of the key players in Neurorehabilitation Robotics Market include Ekso Bionics Holdings, Inc., Cyberdyne Inc., Bionik Laboratories Corp., Hocoma AG (DIH Medical Group), ReWalk Robotics Ltd., Lifeward, Inc., Tyromotion GmbH, Fourier Intelligence, Myomo, Inc., Kinova Inc., Rehab-Robotics Company Limited, AlterG, Inc., Wandercraft SAS, MediTouch Ltd. and Rex Bionics Ltd.
Key Developments:
In January 2026, Lifeward entered a strategic partnership with Oramed to transform into a diversified biomedical innovation company, integrating Oramed’s oral drug delivery technology while gaining access to up to $47 million in funding to support profitability and long-term growth.
In December 2025, Ekso Bionics entered an agreement with MediTouch to become the exclusive U.S. distributor of its BalanceTutor rehabilitation system, expanding its product portfolio and strengthening its position in neurorehabilitation by offering advanced balance training solutions to healthcare providers.
Components Covered:
- Hardware
- Software
- Upper Limb Robots
- Lower Limb Robots
- Exoskeleton Robots
- End-Effector Robots
- Treadmill-Based Robots
- Stroke Rehabilitation
- Spinal Cord Injury Rehabilitation
- Traumatic Brain Injury Rehabilitation
- Cerebral Palsy Rehabilitation
- Parkinson’s Disease Rehabilitation
- Hospitals & Clinics
- Rehabilitation Centers
- Homecare Settings
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY COMPONENT
5.1 Hardware
5.2 Software
6 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY TYPE
6.1 Upper Limb Robots
6.2 Lower Limb Robots
6.3 Exoskeleton Robots
6.4 End-Effector Robots
6.5 Treadmill-Based Robots
7 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY APPLICATION
7.1 Stroke Rehabilitation
7.2 Spinal Cord Injury Rehabilitation
7.3 Traumatic Brain Injury Rehabilitation
7.4 Cerebral Palsy Rehabilitation
7.5 Parkinson’s Disease Rehabilitation
8 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY END USER
8.1 Hospitals & Clinics
8.2 Rehabilitation Centers
8.3 Homecare Settings
9 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Ekso Bionics Holdings, Inc.
12.2 Cyberdyne Inc.
12.3 Bionik Laboratories Corp.
12.4 Hocoma AG (DIH Medical Group)
12.5 ReWalk Robotics Ltd.
12.6 Lifeward, Inc.
12.7 Tyromotion GmbH
12.8 Fourier Intelligence
12.9 Myomo, Inc.
12.10 Kinova Inc.
12.11 Rehab-Robotics Company Limited
12.12 AlterG, Inc.
12.13 Wandercraft SAS
12.14 MediTouch Ltd.
12.15 Rex Bionics Ltd.
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY COMPONENT
5.1 Hardware
5.2 Software
6 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY TYPE
6.1 Upper Limb Robots
6.2 Lower Limb Robots
6.3 Exoskeleton Robots
6.4 End-Effector Robots
6.5 Treadmill-Based Robots
7 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY APPLICATION
7.1 Stroke Rehabilitation
7.2 Spinal Cord Injury Rehabilitation
7.3 Traumatic Brain Injury Rehabilitation
7.4 Cerebral Palsy Rehabilitation
7.5 Parkinson’s Disease Rehabilitation
8 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY END USER
8.1 Hospitals & Clinics
8.2 Rehabilitation Centers
8.3 Homecare Settings
9 GLOBAL NEUROREHABILITATION ROBOTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Ekso Bionics Holdings, Inc.
12.2 Cyberdyne Inc.
12.3 Bionik Laboratories Corp.
12.4 Hocoma AG (DIH Medical Group)
12.5 ReWalk Robotics Ltd.
12.6 Lifeward, Inc.
12.7 Tyromotion GmbH
12.8 Fourier Intelligence
12.9 Myomo, Inc.
12.10 Kinova Inc.
12.11 Rehab-Robotics Company Limited
12.12 AlterG, Inc.
12.13 Wandercraft SAS
12.14 MediTouch Ltd.
12.15 Rex Bionics Ltd.
LIST OF TABLES
Table 1 Global Neurorehabilitation Robotics Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Neurorehabilitation Robotics Market Outlook, By Component (2023-2034) ($MN)
Table 3 Global Neurorehabilitation Robotics Market Outlook, By Hardware (2023-2034) ($MN)
Table 4 Global Neurorehabilitation Robotics Market Outlook, By Software (2023-2034) ($MN)
Table 5 Global Neurorehabilitation Robotics Market Outlook, By Type (2023-2034) ($MN)
Table 6 Global Neurorehabilitation Robotics Market Outlook, By Upper Limb Robots (2023-2034) ($MN)
Table 7 Global Neurorehabilitation Robotics Market Outlook, By Lower Limb Robots (2023-2034) ($MN)
Table 8 Global Neurorehabilitation Robotics Market Outlook, By Exoskeleton Robots (2023-2034) ($MN)
Table 9 Global Neurorehabilitation Robotics Market Outlook, By End-Effector Robots (2023-2034) ($MN)
Table 10 Global Neurorehabilitation Robotics Market Outlook, By Treadmill-Based Robots (2023-2034) ($MN)
Table 11 Global Neurorehabilitation Robotics Market Outlook, By Application (2023-2034) ($MN)
Table 12 Global Neurorehabilitation Robotics Market Outlook, By Stroke Rehabilitation (2023-2034) ($MN)
Table 13 Global Neurorehabilitation Robotics Market Outlook, By Spinal Cord Injury Rehabilitation (2023-2034) ($MN)
Table 14 Global Neurorehabilitation Robotics Market Outlook, By Traumatic Brain Injury Rehabilitation (2023-2034) ($MN)
Table 15 Global Neurorehabilitation Robotics Market Outlook, By Cerebral Palsy Rehabilitation (2023-2034) ($MN)
Table 16 Global Neurorehabilitation Robotics Market Outlook, By Parkinson’s Disease Rehabilitation (2023-2034) ($MN)
Table 17 Global Neurorehabilitation Robotics Market Outlook, By End User (2023-2034) ($MN)
Table 18 Global Neurorehabilitation Robotics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
Table 19 Global Neurorehabilitation Robotics Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 20 Global Neurorehabilitation Robotics Market Outlook, By Homecare Settings (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
Table 1 Global Neurorehabilitation Robotics Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Neurorehabilitation Robotics Market Outlook, By Component (2023-2034) ($MN)
Table 3 Global Neurorehabilitation Robotics Market Outlook, By Hardware (2023-2034) ($MN)
Table 4 Global Neurorehabilitation Robotics Market Outlook, By Software (2023-2034) ($MN)
Table 5 Global Neurorehabilitation Robotics Market Outlook, By Type (2023-2034) ($MN)
Table 6 Global Neurorehabilitation Robotics Market Outlook, By Upper Limb Robots (2023-2034) ($MN)
Table 7 Global Neurorehabilitation Robotics Market Outlook, By Lower Limb Robots (2023-2034) ($MN)
Table 8 Global Neurorehabilitation Robotics Market Outlook, By Exoskeleton Robots (2023-2034) ($MN)
Table 9 Global Neurorehabilitation Robotics Market Outlook, By End-Effector Robots (2023-2034) ($MN)
Table 10 Global Neurorehabilitation Robotics Market Outlook, By Treadmill-Based Robots (2023-2034) ($MN)
Table 11 Global Neurorehabilitation Robotics Market Outlook, By Application (2023-2034) ($MN)
Table 12 Global Neurorehabilitation Robotics Market Outlook, By Stroke Rehabilitation (2023-2034) ($MN)
Table 13 Global Neurorehabilitation Robotics Market Outlook, By Spinal Cord Injury Rehabilitation (2023-2034) ($MN)
Table 14 Global Neurorehabilitation Robotics Market Outlook, By Traumatic Brain Injury Rehabilitation (2023-2034) ($MN)
Table 15 Global Neurorehabilitation Robotics Market Outlook, By Cerebral Palsy Rehabilitation (2023-2034) ($MN)
Table 16 Global Neurorehabilitation Robotics Market Outlook, By Parkinson’s Disease Rehabilitation (2023-2034) ($MN)
Table 17 Global Neurorehabilitation Robotics Market Outlook, By End User (2023-2034) ($MN)
Table 18 Global Neurorehabilitation Robotics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
Table 19 Global Neurorehabilitation Robotics Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 20 Global Neurorehabilitation Robotics Market Outlook, By Homecare Settings (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
